Key result
Pharmacological blockade of selective ion channels with BaCl2 or ivabradine produced complex changes in axonal excitability in vivo, suggesting compensatory accommodation by other ion channels.
Why the study?
Does pharmacological blockade with BaCl2 or ivabradine alter multiple ion channel functions in vivo in normal male mice?
Does pharmacological blockade with BaCl2 or ivabradine alter multiple ion channel functions in vivo in normal male mice?
Pharmacological blockade of a selective ion channel may be compensated by other ion channels, leading to secondary current alterations.
Maintenance of axonal excitability relies on complex balance by multiple ion currents, but its evaluation is limited by in vitro single channel neurophysiological study on overall behavior. We sought to evaluate behaviors of multiple ion currents by pharmacological blockade. The threshold tracking technique was used to measure multiple excitability indices on tail sensory nerve of normal male mice before and after administration of either BaCl2 or ivabradine. Mathematical modeling was used to identify the interval changes of the channel parameters. After administration of BaCl2 and ivabradine, the following changes were present: greater threshold changes of both depolarizing and hyperpolarizing threshold electrotonus by both; additionally, reduced S2 accommodation, reduced late subexcitability and increased superexcitability by BaCl2, increased S3 accommodation by ivabradine. Mathematical modelling implied reduction of slow K+ conductance, along with reduction of H conductance (Ih) by BaCl2; and reduction of Ih while augmentation of K+ conductances by ivabradine. Pharmacological blockade of a selective ion channel may be compensated by other ion channels. Unintended effects by ion channel modification could be caused by secondary current alteration by multiple ion channels. J. Med. Invest. 64: 30-38, February, 2017
No takes yet. Share an insight, caveat, or question.
Banzrai et al. (2017) studied Healthy (normal axonal excitability) (n=12). BaCl2 and ivabradine vs. Baseline (pre-injection) was evaluated on Axonal excitability parameters (e.g., threshold electrotonus, recovery cycle, current-threshold relationship). Pharmacological blockade of selective ion channels with BaCl2 or ivabradine produced complex changes in axonal excitability in vivo, suggesting compensatory accommodation by other ion channels.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: